Current research status of left-sided portal hypertension after superior mesenteric-portal vein confluence pancreaticoduodenectomy / 临床肝胆病杂志
Journal of Clinical Hepatology
; (12): 1482-1487, 2023.
Article
in Zh
| WPRIM
| ID: wpr-978811
Responsible library:
WPRO
ABSTRACT
Surgical operation is the main treatment method for pancreatic cancer, and in clinical practice, radical surgery for pancreatic cancer is often combined with superior mesenteric-portal vein confluence pancreaticoduodenectomy to achieve R0 resection. However, severe left-sided portal hypertension (LSPH) may occur after splenic vein dissection, resulting in a series of pathological changes such as congestive splenomegaly, thrombocytopenia, backflow obstruction of splenic vein, and gastrointestinal varices, and in some cases, it can lead to fatal gastrointestinal hemorrhage and hemorrhagic shock. Therefore, in order to better manage LSPH in clinical practice, this article systematically analyzes and reviews the pathogenesis, treatment regimens, and control strategies of LSPH after combined superior mesenteric-portal vein confluence pancreaticoduodenectomy and put forward corresponding suggestions based on current studies.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Journal of Clinical Hepatology
Year:
2023
Type:
Article